IRON - Disc Medicine, Inc.

QQQ $ 445.88 $ 2.85 (0.64 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.12 $ 1.83 (0.85 %)

Previous Close

$ 31.84

Open

$ 31.76

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 31.63 - $ 32.28

52 Week Range

$ 25.60 - $ 77.60

Volume

393,596

Average Volume

Market Cap

789.95M

Beta (5Y Monthly)

$ 0.10

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-21-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-11-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-31-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-06-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-29-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Disc...
05/10/2024 19:31:20

HC Wainwright & Co. analyst Douglas Tsao reiterates Disc Medicine (NASDAQ:IRON) with a Buy and maintains $70 price target.

Raymond James Maintains Outperform on Disc...
05/10/2024 17:01:51

Raymond James analyst Danielle Brill maintains Disc Medicine (NASDAQ:IRON) with a Outperform and raises the price target fro...

Disc Medicine Q1 EPS $(1.09) Misses $(1.00...
05/09/2024 13:05:15

Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(1.0...

Stifel Maintains Buy on Disc Medicine, Rai...
04/08/2024 12:44:12

Stifel analyst Benjamin Burnett maintains Disc Medicine (NASDAQ:IRON) with a Buy and raises the price target from $71 to $73.

Morgan Stanley Maintains Equal-Weight on D...
04/02/2024 18:02:51

Morgan Stanley analyst Jeffrey Hung maintains Disc Medicine (NASDAQ:IRON) with a Equal-Weight and lowers the price target fr...

BMO Capital Maintains Outperform on Disc M...
04/02/2024 16:14:06

BMO Capital analyst Evan Seigerman maintains Disc Medicine (NASDAQ:IRON) with a Outperform and lowers the price target from ...

Stifel Maintains Buy on Disc Medicine, Low...
04/02/2024 13:02:35

Stifel analyst Benjamin Burnett maintains Disc Medicine (NASDAQ:IRON) with a Buy and lowers the price target from $104 to $71.

top-3-health-care-stocks-youll-regret-missing-this-month

Top 3 Health Care Stocks You'll Regret Mis...
04/02/2024 12:01:59

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Gold Gains 1%; CXApp Shares Spike Higher
04/01/2024 19:02:50

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Monday. The Dow traded down 0....

why-nuvve-holding-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Nuvve Holding Shares Are Trading Lower...
04/01/2024 18:31:11

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expect...

Raymond James Downgrades Disc Medicine to ...
04/01/2024 18:25:57

Raymond James analyst Danielle Brill downgrades Disc Medicine (NASDAQ:IRON) from Strong Buy to Outperform and lowers the pri...

Crude Oil Moves Higher; Oxford Industries ...
04/01/2024 17:47:57

U.S. stocks traded lower midway through trading, with the Dow Jones falling over 300 points on Monday. The Dow traded down 0.7...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/01/2024 16:31:03

disc-medicine-stock-plunges-as-light-sensitivity-treatment-data-confounded-due-to-outsized-placebo-response

Disc Medicine Stock Plunges As Light Sensi...
04/01/2024 14:52:08

Disc Medicine releases AURORA Phase 2 study data on bitopertin for Erythropoietic Protoporphyria. Significant reductions in PPI...

Raymond James Downgrades Disc Medicine to ...
04/01/2024 14:39:41

Raymond James analyst Danielle Brill downgrades Disc Medicine (NASDAQ:IRON) from Strong Buy to Outperform and announces $40 ...

HC Wainwright & Co. Reiterates Buy on Disc...
04/01/2024 13:57:32

HC Wainwright & Co. analyst Douglas Tsao reiterates Disc Medicine (NASDAQ:IRON) with a Buy and maintains $70 price target.

Disc Reports Topline Results From Phase 2 ...
04/01/2024 12:13:23

Met primary endpoint, demonstrating dose-dependent, statistically significant reductions in protoporphyrin IX (PPIX) compared t...

Trading Halt: Halted at 7:55:00 a.m. ET - ...
04/01/2024 11:55:04

HC Wainwright & Co. Maintains Buy on Disc ...
03/22/2024 14:57:20

HC Wainwright & Co. analyst Douglas Tsao maintains Disc Medicine (NASDAQ:IRON) with a Buy and maintains $70 price target.

Disc Medicine Q4 EPS $(0.97) Misses $(0.78...
03/21/2024 12:11:07

Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.7...